Source link : https://www.newshealth.biz/health-news/generic-medicine-okd-by-europe-for-thrombocytopenia-with-hcv/
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for Eltrombopag Viatris (eltrombopag), a generic medicine for the treatment of children and adults with primary immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, and acquired severe aplastic anemia. The application by Viatris Limited relied on […]
Author : News Health
Publish date : 2024-10-18 16:18:26
Copyright for syndicated content belongs to the linked Source.